FDA OKs Johnson & Johnson Vision''s Acuvue Abiliti Overnight lenses for myopia Johnson & Johnson (NYSE:JNJ) unit announces that the FDA has approved ACUVUE Abiliti Overnight Therapeutic Lenses. This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia. Abiliti Overnight contact lenses are expected to be available in the U.S. by the end of 2021. Abiliti Overnight contact lenses are optimized by the use of corneal topography, refractive error and other measurements connected to an innovative fitting software, which provides a precise measure of the corneal shape, and accurately guides the eye care professional through the fitting process for consistent and successful first fit rates of ~90%§. The FDA approval of Abiliti Overnight stems from the collaboration of Johnson & Johnson Vision with Menicon to bring forward therapeutic contact lenses for the treatment of myopia under the ACUVUE Abiliti Brand.
FDA OKs Johnson & Johnson Vision''s Acuvue Abiliti Overnight lenses for myopia Johnson & Johnson (NYSE:JNJ) unit announces that the FDA has approved ACUVUE Abiliti Overnight Therapeutic Lenses. This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia. Abiliti Overnight contact lenses are expected to be available in the U.S. by the end of 2021. Abiliti Overnight contact lenses are optimized by the use of corneal topography, refractive error and other measurements connected to an innovative fitting software, which provides a precise measure of the corneal shape, and accurately guides the eye care professional through the fitting process for consistent and successful first fit rates of ~90%§. The FDA approval of Abiliti Overnight stems from the collaboration of Johnson & Johnson Vision with Menicon to bring forward therapeutic contact lenses for the treatment of myopia under the ACUVUE Abiliti Brand.
FDA OKs Johnson & Johnson Vision''s Acuvue Abiliti Overnight lenses for myopia
Johnson & Johnson (NYSE:JNJ) unit announces that the FDA has approved ACUVUE Abiliti Overnight Therapeutic Lenses. This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia. Abiliti Overnight contact lenses are expected to be available in the U.S. by the end of 2021. Abiliti Overnight contact lenses are optimized by the use of corneal topography, refractive error and other measurements connected to an innovative fitting software, which provides a precise measure of the corneal shape, and accurately guides the eye care professional through the fitting process for consistent and successful first fit rates of ~90%§. The FDA approval of Abiliti Overnight stems from the collaboration of Johnson & Johnson Vision with Menicon to bring forward therapeutic contact lenses for the treatment of myopia under the ACUVUE Abiliti Brand.
OK镜是需要验光师验光定制的吧
是的
不是吧，今年才批准的。 https://www.hcplive.com/view/fda-approves-orthokeratology-contact-lenses-for-myopia-management